background shown vitro prior treatment salmeterol formoterol antagonizes relaxant effect albuterol human bronchi objectives primary aim study evaluate potential vivo interaction beta2agonists presence increased airway tone induced methacholine addition post hoc analysis evaluate effects polymorphisms methods sixteen asthmatic subjects mean age NUMBER NUMBER years fev1 NUMBER NUMBER predicted value taking inhaled corticosteroids having methacholine pd20 values NUMBER micrograms randomized doubledummy fashion receive single doses inhaled placebo inhaled formoterol NUMBER micrograms inhaled salmeterol NUMBER micrograms followed NUMBER hours later single dose inhaled albuterol NUMBER micrograms low dose NUMBER micrograms high dose methacholine challenges performed NUMBER separate occasions NUMBER hour albuterol results greater numerical difference geometric mean pd20 values albuterol placebo dosing NUMBER micrograms vs NUMBER micrograms difference p NUMBER compared albuterol formoterol dosing NUMBER micrograms vs NUMBER micrograms NUMBER difference p NUMBER salmeterol dosing NUMBER micrograms vs NUMBER micrograms difference p NUMBER pd20 values albuterol combination formoterol salmeterol numerically lower albuterol combination placebo significantly different significant difference pd20 values albuterol dosing formoterol pd20 NUMBER micrograms NUMBER difference p NUMBER salmeterol pd20 NUMBER micrograms difference p NUMBER compared pd20 albuterol placebo dosing pd20 NUMBER micrograms post hoc polymorphism analysis pooled pretreatment formoterol salmeterol excluding placebo pretreatment showed significantly p NUMBER lower pd20 values homozygous compared heterozygous significantly p NUMBER lower pd20 values homozygous compared heterozygous homozygous conclusion compared placebo salmeterol formoterol caused significant degree antagonism bronchorelaxation bronchi vivo interaction caused prolonged occupancy airway beta2agonists early tachyphylaxis NUMBER hours exposure degree albuterol protection related polymorphism carbachol contracted long short acting beta2 adrenoceptor sd double blind cross low high dose NUMBER fold low high dose NUMBER fold NUMBER fold high dose high dose low dose NUMBER fold NUMBER fold high dose glycine NUMBER NUMBER glutamate NUMBER NUMBER glutamine NUMBER albuterol induced methacholine contracted beta2 adrenoceptors long acting single dose beta2 adrenoceptor glycine arginine glutamate glutamine